TVGN
Tevogen Bio Holdings Inc.
7.90$
+0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.4% | 31.3% | 71.4% | 73.9% | 82.2% | 68.2% | 75.6% | 48.3% | 47.2% | 35.1% | 43.5% | 42.5% | |
| 41.0% | 19.1% | 39.2% | 34.3% | 54.3% | 37.1% | 48.5% | 16.1% | 23.1% | 12.6% | 14.1% | 22.9% | |
| 41.0% | 19.1% | 39.2% | 34.3% | 54.3% | – | 48.5% | 16.1% | 23.1% | 12.6% | 14.1% | 22.9% | |
| – | 6.3% | 4.7% | 4.8% | 3.7% | – | 3.9% | 3.7% | 3.5% | 3.6% | – | – | |
| 1,526.6% | 1,815.2% | 272.5% | 330.6% | 244.3% | 292.8% | 289.5% | 322.2% | 274.1% | 287.9% | 300.0% | 288.0% | |
| 1,063.6% | 1,552.6% | 265.8% | 320.6% | 242.8% | 261.2% | 214.1% | 189.3% | 149.9% | 161.3% | 147.7% | 130.1% | |
| 1,006.2% | 1,470.6% | 56.8% | 58.0% | 68.1% | – | 44.7% | 46.3% | 44.0% | 45.1% | 40.2% | 41.9% | |
| 29.6% | 62.1% | 155.0% | 201.4% | 136.1% | 150.2% | 114.5% | 99.3% | 73.7% | 76.2% | 77.2% | 59.8% | |
| – | 258.3% | – | – | – | 28.9% | 73.7% | 103.1% | 97.9% | 100.4% | 130.1% | 135.4% | |
| -1,426.6% | -1,715.2% | -172.5% | -230.6% | -144.3% | -192.8% | -189.5% | -222.2% | -174.1% | -187.9% | -200.0% | -188.0% | |
| -1,508.8% | -1,810.1% | -2,628.1% | -2,962.2% | -2,423.2% | -3,275.4% | -3,038.2% | -3,027.7% | -3,003.8% | -3,186.4% | -2,948.7% | -3,191.1% | |
| 49.7% | 58.8% | 84.7% | 93.1% | 79.3% | 102.8% | 79.3% | 86.3% | 87.2% | 75.7% | 70.8% | 81.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.